COVID-19 Pandemic: Opportunity to Reduce, Eliminate Low-Value Practices in Oncology? - For The Media

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 2, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.2404?guestAccessKey=1083a332-d1e8-4136-b773-6c7b17e38742&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070220

What The Viewpoint Says: How the COVID-19 pandemic can reshape care in patients with cancer to focus on discouraging unnecessary in-person visits, testing and low-value treatments is discussed in this article.

Authors: Bishal Gyawali, M.D., Ph.D., of Queen’s University in Kingston, Ontario, Canada, is the corresponding author.

(doi:10.1001/jamaoncol.2020.2404)

Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.